PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	3.93T +57.7%
Revenue (ttm)	2.76T +43.7%
Net Income	-379.67B
EPS	-33.79
Shares Out	11.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,338,200
Average Volume	16,312,930
Open	350.00
Previous Close	350.00
Day's Range	342.00 - 362.00
52-Week Range	161.00 - 700.00
Beta	1.02
RSI	53.39
Earnings Date	Apr 15, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 2,341
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2025, PT Pyridam Farma Tbk's revenue was 2.76 trillion, an increase of 43.71% compared to the previous year's 1.92 trillion. Losses were -379.67 billion, 15.0% more than in 2024.